Search Results - Dustin A Deming

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Advances in immunotherapeutic strategies for colorectal cancer commentary on: tumoral immune cell exploitation in colorectal cancer metastases can be targeted effectively by anti-C... by Dustin A. Deming

    Published in Journal for ImmunoTherapy of Cancer (2016-12-01)
    Get full text
    Article


  2. 2

    Case report: Radiographic complete response of radiation-induced glioblastoma to front-line radiotherapy: A report and molecular characterization of two unique cases by Patrick T. Grogan, Patrick T. Grogan, Patrick T. Grogan, Jeffrey J. Helgager, Dustin A. Deming, Dustin A. Deming, Dustin A. Deming, Steven P. Howard, Steven P. Howard, Robert B. Jenkins, H. Ian Robins, H. Ian Robins, H. Ian Robins, H. Ian Robins

    Published in Frontiers in Neurology (2023-03-01)
    Get full text
    Article


  3. 3

    Molecular Evolution of a Glioblastoma Controlled With Tumor Treating Fields and Concomitant Temozolomide by H. Ian Robins, H. Ian Robins, H. Ian Robins, HuyTram N. Nguyen, Aaron Field, Steven Howard, Shahriar Salamat, Dustin A. Deming, Dustin A. Deming

    Published in Frontiers in Oncology (2018-10-01)
    Get full text
    Article


  4. 4

    The Precision-Guided Use of PI3K Pathway Inhibitors for the Treatment of Solid Malignancies by Alexa E. Schmitz, Shirsa Udgata, Katherine A. Johnson, Dustin A. Deming

    Published in Biomedicines (2025-05-01)
    Get full text
    Article


  5. 5

    The conserved protective cyclic AMP-phosphodiesterase function PDE4B is expressed in the adenoma and adjacent normal colonic epithelium of mammals and silenced in colorectal cancer... by Jennifer K Pleiman, Amy A Irving, Zhishi Wang, Erik Toraason, Linda Clipson, William F Dove, Dustin A Deming, Michael A Newton

    Published in PLoS Genetics (2018-09-01)
    Get full text
    Article


  6. 6

    Precision medicine in colorectal cancer: the molecular profile alters treatment strategies by Nguyen H. Tran, Ludimila L. Cavalcante, Sam J. Lubner, Daniel L. Mulkerin, Noelle K. LoConte, Linda Clipson, Kristina A. Matkowskyj, Dustin A. Deming

    Published in Therapeutic Advances in Medical Oncology (2015-09-01)
    Get full text
    Article


  7. 7

    mTOR inhibition elicits a dramatic response in PI3K-dependent colon cancers. by Dustin A Deming, Alyssa A Leystra, Mohammed Farhoud, Laura Nettekoven, Linda Clipson, Dawn Albrecht, Mary Kay Washington, Ruth Sullivan, Jamey P Weichert, Richard B Halberg

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


  8. 8

    Metabolic Heterogeneity in Patient Tumor-Derived Organoids by Primary Site and Drug Treatment by Joe T. Sharick, Joe T. Sharick, Christine M. Walsh, Carley M. Sprackling, Cheri A. Pasch, Dan L. Pham, Dan L. Pham, Karla Esbona, Alka Choudhary, Alka Choudhary, Rebeca Garcia-Valera, Rebeca Garcia-Valera, Rebeca Garcia-Valera, Mark E. Burkard, Mark E. Burkard, Stephanie M. McGregor, Stephanie M. McGregor, Kristina A. Matkowskyj, Kristina A. Matkowskyj, Kristina A. Matkowskyj, Alexander A. Parikh, Ingrid M. Meszoely, Mark C. Kelley, Susan Tsai, Dustin A. Deming, Dustin A. Deming, Dustin A. Deming, Melissa C. Skala, Melissa C. Skala, Melissa C. Skala

    Published in Frontiers in Oncology (2020-05-01)
    Get full text
    Article


  9. 9

    Cellpose as a reliable method for single-cell segmentation of autofluorescence microscopy images by Jeremiah M. Riendeau, Amani A. Gillette, Emmanuel Contreras Guzman, Mario Costa Cruz, Aleksander Kralovec, Shirsa Udgata, Alexa Schmitz, Dustin A. Deming, Beth A. Cimini, Melissa C. Skala

    Published in Scientific Reports (2025-02-01)
    Get full text
    Article


  10. 10

    Phospholipid ether analogs for the detection of colorectal tumors. by Dustin A Deming, Molly E Maher, Alyssa A Leystra, Joseph P Grudzinski, Linda Clipson, Dawn M Albrecht, Mary Kay Washington, Kristina A Matkowskyj, Lance T Hall, Sam J Lubner, Jamey P Weichert, Richard B Halberg

    Published in PLoS ONE (2014-01-01)
    Get full text
    Article


  11. 11

    Subclonal response heterogeneity to define cancer organoid therapeutic sensitivity by Jeremy D. Kratz, Shujah Rehman, Katherine A. Johnson, Amani A. Gillette, Aishwarya Sunil, Peter F. Favreau, Cheri A. Pasch, Devon Miller, Lucas C. Zarling, Austin H. Yeung, Linda Clipson, Samantha J. Anderson, Alyssa K. Steimle, Carley M. Sprackling, Kayla K. Lemmon, Daniel E. Abbott, Mark E. Burkard, Michael F. Bassetti, Jens C. Eickhoff, Eugene F. Foley, Charles P. Heise, Randall J. Kimple, Elise H. Lawson, Noelle K. LoConte, Sam J. Lubner, Daniel L. Mulkerin, Kristina A. Matkowskyj, Cristina B. Sanger, Nataliya V. Uboha, Sean J. Mcilwain, Irene M. Ong, Evie H. Carchman, Melissa C. Skala, Dustin A. Deming

    Published in Scientific Reports (2025-04-01)
    Get full text
    Article


Search Tools: